Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lancaster Resources Inc. C.LCR

Alternate Symbol(s):  LANRF

Lancaster Resources Inc. is a Canada-based company engaged in exploring lithium and uranium and other critical minerals. The Company’s Alkali Flat Lithium Project, which covers approximately 5,200 acres in Lordsburg, New Mexico, United States, and is involved in the exploration of a below-surface lithium brine target. The Company holds a 100% interest in the Catley Lalk and Centennial East Uranium project in the Athabasca Basin in Saskatchewan, Canada. The two properties, named Catley Lake and Centennial East, cover over 3,036 and 5,081 hectares respectively. Its project portfolio also includes rights to acquire the Trans-Taiga Lithium Property located within the James Bay lithium district of Quebec and covers over 3,520 acres. The Company’s Piney Lake Gold Property covers an area of 2,267.8 hectares, is nestled approximately 65 kilometers east of La Ronge Provincial Park and a mere 2.5 km east of North Arrow Minerals' Pikoo property.


CSE:LCR - Post by User

Post by Viralstocks1on Mar 24, 2021 12:02pm
204 Views
Post# 32866635

CEO Provides Update On The Progress Of Its Psilocybin Drug

CEO Provides Update On The Progress Of Its Psilocybin Drug News Release (23-03-21): NeonMind (CSE: NEON) (OTC: NMDBF) CEO Provides Update On The Progress Of Its Psilocybin Drug Development Research Plan And Team. Read Here: https://neonmindbiosciences.com/neonmind-ceo-provides-update-on-the-progress-of-its-psilocybin-drug-development-research-plan-and-team/
<< Previous
Bullboard Posts
Next >>